Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules and drug candidates. Its structure, featuring a Boc-protected piperidine with a pyrrolidine amide substituent, supports the introduction of pyrrolidine and piperidine motifs, which are common in medicinal chemistry for enhancing metabolic stability and binding affinity. The tert-butoxycarbonyl (Boc) group protects the piperidine nitrogen, enabling regioselective reactions and facile deprotection. Commonly employed in the preparation of protease inhibitors and receptor modulators. Also utilized in research settings for library synthesis in structure-activity relationship (SAR) studies.